Highbridge Capital Management LLC Pfizer Inc Call Options Transaction History

Highbridge Capital Management LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $11 Million - $11.7 Million	-333,700 Reduced 95.34%	16,300 $594,000
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $10.9 Million - $12.7 Million	342,900 Added 4829.58%	350,000 $12.4 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $33.5 Million - $35.5 Million	-1,006,400 Reduced 99.3%	7,100 $258,000
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $31.4 Million - $34.6 Million	1,013,500	1,013,500 $36.2 Million

3,158

3.68B

67.4M

113M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $156B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Highbridge Capital Management LLC with notifications on news.